WOLFGANG WINKELMAYER to Evidence-Based Medicine
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Evidence-Based Medicine.
Connection Strength
0.559
-
Comparative effectiveness research: what is it and why do we need it in nephrology? Nephrol Dial Transplant. 2012 Jun; 27(6):2156-61.
Score: 0.284
-
Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach. Ann Intern Med. 2020 09 15; 173(6):489-491.
Score: 0.123
-
Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysis. Semin Dial. 2010 Sep-Oct; 23(5):486-91.
Score: 0.063
-
Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002 Sep-Oct; 22(5):417-30.
Score: 0.036
-
Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a?Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018 06; 93(6):1281-1292.
Score: 0.027
-
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving?Global Outcomes (KDIGO) Controversies?Conference. Kidney Int. 2018 03; 93(3):545-559.
Score: 0.026